D Larrey

Summary

Country: France

Publications

  1. doi request reprint Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin
    Dominique Larrey
    Liver Unit and CIC IRB1040, Saint Eloi Hospital, Montpellier, France
    Antivir Ther 17:927-32. 2012
  2. doi request reprint Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin
    Dominique Larrey
    Servise d Hépato Gastro Entérologie et Transplantation, Hopital Saint Eloi, 80 avenue Augustin Fliche, 34295 Montepellier, France
    J Hepatol 57:39-46. 2012
  3. doi request reprint Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-α2a and ribavirin
    Dominique Larrey
    Hepato Gastroenterology, Saint Eloi Hospital, Montpellier, France
    Clin Gastroenterol Hepatol 9:781-5. 2011
  4. pmc Is chronic hepatitis C virus infection a risk factor for breast cancer?
    Dominique Larrey
    Liver Unit and INSERM Unit 632, Saint Eloi Hospital, Montpellier University, 80 rue Augustin Fliche, Montpellier Cedex 5, France
    World J Gastroenterol 16:3687-91. 2010
  5. doi request reprint [Hepatotoxicity of immunosuppressants. Diagnostic approach]
    D Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, 80, rue Augustin Fliche, 34295 Montpellier Cedex 5, France
    Gastroenterol Clin Biol 32:S194-204. 2008
  6. ncbi request reprint [Chronic hepatitis C: management of side effects of treatment]
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, CHU Montpellier et INSERM U632, 80 rue Augustin Fliche, Montpellier Cedex 5
    Gastroenterol Clin Biol 31:4S20-8. 2007
  7. ncbi request reprint [Is there a risk to prescribe paracetamol at therapeutic doses in patients with acute or chronic liver disease?]
    Dominique Larrey
    Service d Hépatogastro entérologie et Transplantation hépatique, Hopital Saint Eloi, Montpellier
    Gastroenterol Clin Biol 30:753-5. 2006
  8. pmc Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?
    P Aguilar-Martinez
    Laboratory of Haematology, CHU of Montpellier, 34295 Montpellier, France
    Gut 48:836-42. 2001
  9. ncbi request reprint Cross hepatotoxicity between tricyclic antidepressants and phenothiazines
    A J Remy
    Department of Hepato Gastroenterology, Saint Eloi Hospital, Montpellier, France
    Eur J Gastroenterol Hepatol 7:373-6. 1995
  10. ncbi request reprint Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients
    O Dereure
    Department of Dermatology Phlebology, CHRU Montpellier, Hopital Saint Eloi, 80 avenue Augustin Fliche, 34265 Montpellier cedex 5, France
    Br J Dermatol 147:1142-6. 2002

Collaborators

Detail Information

Publications29

  1. doi request reprint Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin
    Dominique Larrey
    Liver Unit and CIC IRB1040, Saint Eloi Hospital, Montpellier, France
    Antivir Ther 17:927-32. 2012
    ..After the protocol-defined phase, patients were free to continue with PEG-IFN/RBV. Sustained virological response (SVR) was evaluated in patients who continued treatment with PEG-IFN/RBV...
  2. doi request reprint Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin
    Dominique Larrey
    Servise d Hépato Gastro Entérologie et Transplantation, Hopital Saint Eloi, 80 avenue Augustin Fliche, 34295 Montepellier, France
    J Hepatol 57:39-46. 2012
    ..BI 207127 is a potent non-nucleoside hepatitis C virus (HCV) NS5B polymerase inhibitor in vitro...
  3. doi request reprint Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-α2a and ribavirin
    Dominique Larrey
    Hepato Gastroenterology, Saint Eloi Hospital, Montpellier, France
    Clin Gastroenterol Hepatol 9:781-5. 2011
    ..We performed a prospective study to determine the effects of systematic consultation by a nurse on patient adherence and the efficacy of therapy...
  4. pmc Is chronic hepatitis C virus infection a risk factor for breast cancer?
    Dominique Larrey
    Liver Unit and INSERM Unit 632, Saint Eloi Hospital, Montpellier University, 80 rue Augustin Fliche, Montpellier Cedex 5, France
    World J Gastroenterol 16:3687-91. 2010
    ..To evaluate the prevalence of breast tumors in adult females with chronic hepatitis C virus (HCV) infection...
  5. doi request reprint [Hepatotoxicity of immunosuppressants. Diagnostic approach]
    D Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, 80, rue Augustin Fliche, 34295 Montpellier Cedex 5, France
    Gastroenterol Clin Biol 32:S194-204. 2008
  6. ncbi request reprint [Chronic hepatitis C: management of side effects of treatment]
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, CHU Montpellier et INSERM U632, 80 rue Augustin Fliche, Montpellier Cedex 5
    Gastroenterol Clin Biol 31:4S20-8. 2007
    ..It is also essential to provide a well adapted therapeutic education to get an optimal compliance to the treatment and thereby a better chance of success...
  7. ncbi request reprint [Is there a risk to prescribe paracetamol at therapeutic doses in patients with acute or chronic liver disease?]
    Dominique Larrey
    Service d Hépatogastro entérologie et Transplantation hépatique, Hopital Saint Eloi, Montpellier
    Gastroenterol Clin Biol 30:753-5. 2006
  8. pmc Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?
    P Aguilar-Martinez
    Laboratory of Haematology, CHU of Montpellier, 34295 Montpellier, France
    Gut 48:836-42. 2001
    ..But few H63D homozygotes with clinical manifestations of hereditary haemochromatosis (HH) have been reported. Concurrently, an increasing number of genes have been shown to interact with HFE in iron metabolism...
  9. ncbi request reprint Cross hepatotoxicity between tricyclic antidepressants and phenothiazines
    A J Remy
    Department of Hepato Gastroenterology, Saint Eloi Hospital, Montpellier, France
    Eur J Gastroenterol Hepatol 7:373-6. 1995
    ..To describe a case of cross hepatotoxicity between tricyclic antidepressants and phenothiazines...
  10. ncbi request reprint Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients
    O Dereure
    Department of Dermatology Phlebology, CHRU Montpellier, Hopital Saint Eloi, 80 avenue Augustin Fliche, 34265 Montpellier cedex 5, France
    Br J Dermatol 147:1142-6. 2002
    ..By contrast, very few data are available with regard to distant skin reactions, particularly inflammatory lesions on other parts of the body...
  11. ncbi request reprint Drug-induced liver diseases
    D Larrey
    Service d Hépatogastro entérologie et Transplantation hépatique, Hopital Saint Eloi, Montpellier, France
    J Hepatol 32:77-88. 2000
    ..The prediction of the hepatotoxicity of new drugs must be improved. Investigations would be particularly useful for drugs having critical chemical structures and belonging to families with an established history of hepatotoxicity...
  12. ncbi request reprint Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis
    P Aguilar-Martinez
    Laboratory of Hematology, CHU de Montpellier, Montpellier, France
    Blood Cells Mol Dis 27:290-3. 2001
    ..Concurrently, none of the 18 hereditary hemochromatosis patients who had their TFR2 gene sequenced had any deleterious mutation. Thus, TFR2 mutations are not responsible for hemochromatosis in non-C282Y homozygous patients of our area...
  13. ncbi request reprint Nocardiosis revealed by thyroid abscess in a liver--kidney transplant recipient
    A Vandĵme
    Fédération Médicochirurgicale, Hopital Saint Eloi, Montpellier, France
    Transpl Int 14:202-4. 2001
    ..Clinicians should be aware of this entity, as Nocardia Asteroides may need more than 5 days of culture to be isolated...
  14. ncbi request reprint Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?
    Georges Philippe Pageaux
    Fédération médico chirurgicale d Hépato gastroentérologie et Transplantation, Hopital Saint Eloi, 80 rue Augustin Fliche, 34295 CHU Montpellier Cedex 5, France
    J Hepatol 38:629-34. 2003
    ..The aim of this study was to distinguish the types of alcohol consumption after liver transplantation (LT) for alcoholic cirrhosis and to assess the consequences of heavy drinking...
  15. ncbi request reprint Epidemiology and individual susceptibility to adverse drug reactions affecting the liver
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, Montpellier, France
    Semin Liver Dis 22:145-55. 2002
    ....
  16. ncbi request reprint Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation
    Georges Philippe Pageaux
    Liver Transplant Unit, Centre Hospitalier Universitaire CHU Saint Eloi, Montpellier, France
    Liver Transpl 12:1755-60. 2006
    ....
  17. ncbi request reprint [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?]
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, CHU Montpellier
    Gastroenterol Clin Biol 26:B283-90. 2002
  18. ncbi request reprint Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease?
    Pascal Perney
    Service de Médecine Interne E, Hopital Saint Eloi, Montpellier Cedex, France
    Transpl Int 18:1292-7. 2005
    ..05). Information on previous alcohol consumption (dependence, number of withdrawals, family history) helps to predict severe relapse after LT in patients with ALD, allowing early awareness and specific postoperative care...
  19. ncbi request reprint Drug-induced acute liver failure
    Dominique Larrey
    Department of Gastroenterology, Hepatology and Liver Transplantation, Hopital Saint Eloi, Montpellier School of Medicine and INSERM Unit 632, Montpellier, France
    Eur J Gastroenterol Hepatol 17:141-3. 2005
    ..At the stage of liver failure, treatment is mostly supportive. Since irreversible damage is unpredictable, early transfer to a transplantation centre should be considered...
  20. ncbi request reprint [From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication]
    Dominique Larrey
    Service d hépatogastroentérologie et transplantation Hôpital Saint Eloi, 80 rue Augustin Fliche 34295 Montpellier
    Presse Med 32:512-8. 2003
    ..Other treatments are currently proposed (anti-oxidants, insulin-resistance modulators), but none of them have presently been completely validated...
  21. ncbi request reprint Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy
    Stefan Mauss
    Center for HIV and Hepatogastroenterology, Dusseldorf, Germany
    AIDS 18:F21-5. 2004
    ..This paper identifies risk factors associated with hepatic decompensation in APRICOT...
  22. ncbi request reprint [Bacterial hepatitis]
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, CHU Montpellier, 80, rue Augustin Fliche, 34295 Montpellier Cedex 5
    Gastroenterol Clin Biol 27:B27-31. 2003
  23. ncbi request reprint [Non-alcoholic steatohepatitis: natural history and diagnosis]
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, CHU Montpellier
    Gastroenterol Clin Biol 27:793-8. 2003
  24. ncbi request reprint Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients
    Christophe Duvoux
    Liver Transplant Unit, AP HP Hopital Henri Mondor, 51 Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Transplantation 74:1103-9. 2002
    ..The aim of this work was to identify specific risk factors for lymphoproliferative disorders after liver transplantation in adults...
  25. ncbi request reprint Hepatic findings in long-term clinical trials of ximelagatran
    William M Lee
    University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9151, USA
    Drug Saf 28:351-70. 2005
    ..In these studies, raised aminotransferase levels were observed during long-term use (>35 days). The aim of this analysis is to review the data regarding these hepatic findings in the long-term trials of ximelagatran...
  26. pmc Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro
    Valerie Castet
    INSERM U128, Montpellier, France
    J Virol 76:8189-99. 2002
    ..These results show that IFN-alpha acts primarily through its nonspecific antiviral effects and suggest that primary cultures of human hepatocytes may provide a good model to study intrinsic HCV resistance to IFN-alpha...
  27. ncbi request reprint SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders
    Christoph Sarrazin
    Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    Gastroenterology 132:1270-8. 2007
    ....
  28. ncbi request reprint Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance
    Eric Assenat
    Service de Chirurgie Digestive, Hopital Saint Eloi, Montpellier, France
    Hepatology 40:951-60. 2004
    ....
  29. ncbi request reprint Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial
    Diego Garcia-Compean
    Service d Hepato Gastroenterologie, Hopital Saint Eloi, Montpellier, France
    Ann Hepatol 1:29-35. 2002
    ..05). Ascites recurrence rates and survival were similar in the two groups. In conclusion, Dextran-40 was thus not as efficacious as albumin for preventing PCD...